Drug Search Results
More Filters [+]

Gadoxetic acid

Alternative Names: gadoxetic acid
Latest Update: 2025-01-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Bosnia | Brazil | Bulgaria | Canada | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | Finland | Germany | Greece | Hungary | Iceland | Indonesia | Ireland | Italy | Korea | Latvia | Lithuania | Malta | Netherlands | New Zealand | Norway | Peru | Philippines | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Sweden | Switzerland | Taiwan | Thailand | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gadoxetic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title